Baldwin Investment Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,000
| Closed | -$243K | – | 209 |
|
|
2024
Q4 | $243K | Sell |
2,000
-250
| -11% | -$30.4K | 0.03% | 188 |
|
|
2024
Q3 | $281K | Hold |
2,250
| – | – | 0.04% | 186 |
|
|
2024
Q2 | $356K | Hold |
2,250
| – | – | 0.05% | 167 |
|
|
2024
Q1 | $291K | Sell |
2,250
-50
| -2% | -$6.47K | 0.04% | 186 |
|
|
2023
Q4 | $222K | Hold |
2,300
| – | – | 0.03% | 196 |
|
|
2023
Q3 | $279K | Hold |
2,300
| – | – | 0.05% | 169 |
|
|
2023
Q2 | $263K | Hold |
2,300
| – | – | 0.04% | 176 |
|
|
2023
Q1 | $317K | Hold |
2,300
| – | – | 0.06% | 169 |
|
|
2022
Q4 | $298K | Hold |
2,300
| – | – | 0.05% | 173 |
|
|
2022
Q3 | $254 | Buy |
+2,300
| New | +$254 | 0.05% | 183 |
|
|
2022
Q1 | – | Sell |
-2,300
| Closed | -$207 | – | 258 |
|
|
2021
Q4 | $207 | Hold |
2,300
| – | – | 0.03% | 244 |
|
|
2021
Q3 | $213K | Buy |
+2,300
| New | +$213K | 0.04% | 236 |
|
|
2021
Q1 | – | Sell |
-2,300
| Closed | -$392K | – | 252 |
|
|
2020
Q4 | $392K | Hold |
2,300
| – | – | 0.08% | 163 |
|
|
2020
Q3 | $323K | Sell |
2,300
-500
| -18% | -$70.2K | 0.08% | 157 |
|
|
2020
Q2 | $449K | Hold |
2,800
| – | – | 0.14% | 101 |
|
|
2020
Q1 | $274K | Sell |
2,800
-400
| -13% | -$39.1K | 0.09% | 121 |
|
|
2019
Q4 | $413K | Sell |
3,200
-100
| -3% | -$12.9K | 0.11% | 123 |
|
|
2019
Q3 | $249K | Hold |
3,300
| – | – | 0.07% | 146 |
|
|
2019
Q2 | $501K | Hold |
3,300
| – | – | 0.14% | 107 |
|
|
2019
Q1 | $393K | Hold |
3,300
| – | – | 0.12% | 118 |
|
|
2018
Q4 | $360K | Hold |
3,300
| – | – | 0.11% | 114 |
|
|
2018
Q3 | $533K | Hold |
3,300
| – | – | 0.15% | 99 |
|
|
2018
Q2 | $436K | Buy |
+3,300
| New | +$436K | 0.14% | 110 |
|